Top searches

PL

Resources

B2RLaw advised on the investment of the Vinci S.A. HiTech ASI S.K.A. fund into OASIS Diagnostics S.A. for nearly PLN 14 million

09/08/2023

OASIS is a Polish MedTech start-up that designed and developed an innovative system ONIRY and medical device for diagnostics in response to the need to find a suitable method to detect pelvic floor muscles injuries immediately after delivery and effective way to prevent serious complications from these injuries later in life. Their clinical-knowledge-based technology detects the problem in 1-minute procedure.

“The nearly PLN 14 million investment raised will allow us to complete the product certification activities in the EU, initiate the certification procedure at the FDA, start production and launch the product on the market in 2023. We also plan to conduct extensive clinical trials to confirm the benefits of implementing the early diagnosis of perinatal injuries with the ONIRA method into clinical practice.” – says Edyta Hryniecka, a Member of the Oasis Board, leading the investor acquisition process.

“Our innovative system for detecting perinatal injuries, ONIRY, will soon allow us allow us to perform a simple, painless, fast and precise examination, assessing the condition of the pelvic floor muscles, in any woman who has just given birth by natural forces.” – says Oasis CEO Katarzyna Borycka.

Vinci (which manages HiTech ASI fund) advises, “Together, we believe that ONIRY will become an important element in the standard of perinatal care and we plan to support the company in pursuit of this goal.”

B2RLaw Partner Agnieszka Hajos-Iwańska comments, “This is a project with huge potential to revolutionise its industry. Vinci’s investment of nearly PLN 14 million will be spent on certification of the medical device and commercialization of the solution. We are all the more pleased to be a part of it, legally supporting the investment process.”

B2RLaw’s team was led by Agnieszka Hajos-Iwańska (Advocate, Partner) and included Malwina Niczke-Chmura (Advocate, Counsel), Paulina Wyrostek (Attorney-at-law, Counsel), Konrad Czernecki (Associate, Attorney at Law Trainee), Małgorzata Tomaka (Junior Associate) and Krzysztof Judasz (Junior Associate).

View more resources

Catch up on the very latest B2RLAW
announcements and news here.

04/10/2023

B2RLaw as Legal Partner at Warsaw Security Forum 2023

The Warsaw Security Forum (”WSF”) is one of the leading European conferences dedicated to transatlantic cooperation and focusing on developing […]

MORE
02/10/2023

B2RLaw’s experts author The Legal 500: White Collar Crime Country Comparative Guide

B2RLaw’s experts: Bartłomiej Jankowski (Advocate, Senior Partner), Kinga Karaszewska (Advocate, Associate) and Jakub Przybyliński (Advocate, Associate) have once again been invited […]

MORE
27/09/2023

B2RLaw advised White Star Real Estate on the sale of a group of companies from the short-term lease market sector to Renters.pl

B2RLaw advised White Star Real Estate on the sale of a group of companies from the short-term lease market sector […]

MORE
15/09/2023

B2RLaw recommended in IFLR1000 ranking 2023

We are proud to announce that in this year’s edition of IFLR1000 ranking we have been recommended in 3 categories. […]

MORE
11/09/2023

B2RLaw advised Sprout Social Inc. USD 140M acquisition of Tagger Media Inc.

B2RLaw advised Sprout Social Inc. on its USD 140M acquisition of Tagger Media Inc. and key software developed by Tagger’s […]

MORE
07/09/2023

B2RLaw at XXXI International Defense Industry Exhibition MSPO 2023

Let’s meet at the 31st International Defense Industry Exhibition MSPO at Targi Kielce S.A. – the largest event of Polish […]

MORE

Get in touch

Not sure who to contact? Let us help you find the right lawyer.

This site uses cookies to improve your experience More information.

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close